Federal contract award
75N93020C00032
CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC)
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NIAID |
| NAICS | 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| PSC | AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | COST PLUS FIXED FEE |
| Obligations | $63.0M |
| Current contract value | $63.0M |
| Potential contract value / ceiling | $85.3M |
| Start date | Jun 16, 2020 |
| Current end date | Jun 15, 2027 |
| Potential end date | Jun 15, 2027 |
| Latest award activity | Sep 4, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 18 of 18 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 4, 2026 | P00017 | $-597.3K | CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Aug 10, 2026 | P00016 | $-529.5K | EO14398; CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Jun 8, 2026 | P00015 | $8.9M | CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Sep 9, 2025 | P00014 | $-400.8K | CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Jun 3, 2025 | P00013 | $8.6M | CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Apr 22, 2024 | P00012 | $8.4M | CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Jul 27, 2023 | P00011 | $735.7K | CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| May 8, 2023 | P00010 | $9.1M | CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Sep 15, 2022 | P00009 | $717.4K | EXERCISE OPTION 9 (QUANTITY OPTION) TO SUPPORT MONKEY POX RELATED WORK. CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Jun 9, 2022 | P00008 | $8.5M | COVID 19 RELATED WORK UNDER OPTION 37 - CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Feb 16, 2022 | P00007 | $0 | CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Jan 11, 2022 | P00006 | $699.6K | COVID -19 CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Dec 2, 2021 | P00005 | $0 | EO14042 CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Jun 8, 2021 | P00004 | $9.5M | COVID-19 RELATED WORK - CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Dec 3, 2020 | P00003 | $514.5K | COVID-19 RELATED WORK - CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Sep 22, 2020 | P00002 | $0 | CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Aug 12, 2020 | P00001 | $1.2M | COVID-19 RELATED WORK - CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
| Jun 15, 2020 | 0 | $7.6M | CLINICAL RESEARCH PRODUCTS DEVELOPMENT CENTER (CRPMC) |
Estimated positioning window
Oct 25, 2026 – Jan 23, 2027
80/100
Why this recompete signal
Contract timing and recorded acquisition signals at the time of calculation.
Stored score: 80/100. Available recorded signals: 75 points.
- Contract end 2027-06-15 (233 days from calculation)
- +35 points
- 155 historical awards in this buyer and category group
- +15 points
- 18 recorded award transactions
- +10 points
- Latest award action: 2026-09-04
- +5 points
- Parent award identifier recorded
- +0 points
- Solicitation identifier recorded
- +10 points
- Linked official forecast
- +0 points
- Calculated on
- 2026-10-25 10:18:04.631876+00:00
The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.
Rule-based research score; it does not measure your chance of winning.
This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.
Recompete score calculated Oct 25, 2026.
Research next steps
- Check the linked forecast or SAM for a confirmed solicitation and current timing.
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.